UMIN ID: UMIN000037723
Registered date:26/08/2019
A biomarker study of soluble immune markers in stage II-IIIA non-small cell lung cancer (WJOG12319LTR)
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Resectable stage II-IIIA non-small cell lung cancer |
| Date of first enrollment | 2019/09/01 |
| Target sample size | 200 |
| Countries of recruitment | Japan |
| Study type | Observational |
| Intervention(s) |
Outcome(s)
| Primary Outcome | Association of soluble immune markers, including soluble PD-L1, soluble PD-1, soluble CTLA-4, and relapse-free survival / overall survival in resectable stage II-IIIA NSCLC |
|---|---|
| Secondary Outcome | Association of soluble immune markers, including soluble PD-L1, soluble PD-1, soluble CTLA-4, and clinical background / characteristics |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | 75years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | None |
Related Information
| Primary Sponsor | West Japan Oncology Group |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | None |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Shinichiro Nakamura |
| Address | Namba Plaza Bldg. 304-1-5-7, Motomachi Naniwa-ku, Osaka, JAPAN Japan 556-0016 |
| Telephone | 06-6633-7400 |
| datacenter@wjog.jp | |
| Affiliation | West Japan Oncology Group WJOG datacenter |
| scientific contact | |
| Name | Hidetoshi Hayashi |
| Address | 377-2, Ohno-higashi, Osaka-Sayama, 589-8511, Japan Japan |
| Telephone | 072-366-0221 |
| hidet31@med.kindai.ac.jp | |
| Affiliation | Kindai University, Faculty of Medicine Department of Medical Oncology |